# Contrast-enhanced CBCT With C-arm HyperSight Technology

> **NCT07648160** · NA · RECRUITING · sponsor: **University Health Network, Toronto** · enrollment: 20 (estimated)

## Conditions studied

- Advanced Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Intravenous contrast-enhanced cone beam computed tomography

## Key facts

- **NCT ID:** NCT07648160
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-24
- **Primary completion:** 2027-07-01
- **Final completion:** 2027-07-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07648160

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07648160, "Contrast-enhanced CBCT With C-arm HyperSight Technology". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07648160. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*